Estudio comparativo de la tasa de incidencia de cáncer entre pacientes con Síndrome de Apneas-Hipoapneas durante el Sueño y la población general

Comparative study of the incidence rate of cancer and main types of tumors among patients with Obstructive Sleep Apnea Syn-drome against the general population

  • Diana E Castilla Perera Gerencia Regional de Salud de Castilla y León (Valladolid, España)
  • Paloma Burgos Díez Gerencia Regional de Salud de Castilla y León (Valladolid, España)
  • Félix del Campo Matías Gerencia Regional de Salud de Castilla y León (Valladolid, España)
  • Tomás Ruíz Albi Gerencia Regional de Salud de Castilla y León (Valladolid, España)
Palabras clave: SAHS, Cáncer, IAH, Hipoxia intermitente
Key-words: SAHS, Cancer, IAH, Intermittent hypoxia

Resumen

Abstract

Bibliografía

1. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010; 7: 677–85.
2. Budhiraja R, Parthasarathy S, Quan SF. Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med. 2007; 3:409–15.
3. Manni R, Terzaghi M, Arbasino C, Sartori I, Galimberti CA, Tartara A. Obstructive sleep apnea in a clinical series of adult epi-lepsy patients: frequency and features of the comorbidity. Epilepsia. 2003; 44:836-840.
4. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol. 2004; 160:521-530.
5. Verstraeten E. Neurocognitive effects of obstructive sleep apnea syndrome. Curr Neurol Neurosci Rep. 2007;7:161-166.
6. Zhang XB, Peng LH, Lyu Z, Jiang XT, Du YP. Obstructive sleep apnea and the incidence and mortality of cancer: a metaanal-ysis. Eur J Cancer Care 26(2). (doi: 10.1111/ecc.12427). [acceso: 02/09/2018].
7. Muz B, de la Puente P, Azab F, Azab AK. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015.2015;3: 83-92.
8. Lloberes P, Durán-Cantolla J, Martínez-García MÁ, Marín JM, et al. Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueño. Arch Bronconeumol. 2011; 47: 143-56.
9. Nemanja D Marjanovic, Robert A Weinberg, Christine L Chaffer. Cell Plasticity and Heterogeneity in Cancer. Clinical Chemis-try. 2013; 59:1.168–179.
10. Almendros I, Martinez-Garcia MA, Obeso A, y Gozal D. Obstructive Sleep Apnea and Cancer: Insights from Intermittent Hypoxia Experimental Models. Current Sleep Medicine Reports. 2017; 3:22–29.
11. Almendros I, Monserrat JM, Ramírez J, Torres M, et al. Intermittent hypoxia enhances cancer progression in mouse model of sleep apnea. Eur Respir J. 2012;39 (1):215-7.
12. Almendros I, Monserrat JM, Torres M, Bonsignore MR, et al. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea. Sleep Med. 2012;13(10):1254-60.
13. Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, Duran-Cantolla J, et al. Association between obstructive sleep ap-nea and cancer incidence in a large multicenter spanish cohort. American journal of respiratory critical care medicine 2013; 187(1):99–105.
14. F.J. Nieto,P. E. Peppard,T. Young,L. Finn,K.M. Hla,R. Farre Sleep-disordered breathing and cancer mortality: Results from the Wisconsin Sleep Cohort Study Am J Respir Crit Care Med. 2012; 186:190-194.
15. Almendros I, Gozal D. Intermittent hypoxia and cancer: Undesirable bed partners?. Respiratory Physiology & Neurobiology journal. 2017; 1569-9048.
16. Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep. 2016; 39(8):1493-1500.
17. Kendzerska T, Leung RS, Hawker G, Tomlinson G, Gershon AS. Obstructive sleep apnea and the prevalence and incidence of cancer. CMAJ 2014; 186:985–92.
18. Instituto Nacional de Estadística. Estadística del Padrón Continuo. Datos a nivel nacional, comunidad autónoma y provin-cia. Última consulta el 1 de octubre de 2018. (Disponible en http://www.ine.es/jaxi/Tabla.htm?path=/t20/e245/p04/a2005/l0/&file=00000002.px&L=0). [acceso: 10/11/2018].
19. Portal de Salud de Castilla y León (SACYL). Registro poblacional de Cáncer. (Disponible en: https://www.saludcastillayleon.es/profesionales/es/informacion-epidemiologica/registro-poblacional-cancer/acceso-registro-poblacional-cancer). [acceso: 11/07/2018].
20. Bray F, Colombet M, Mery L, Piñeros M, et al. Cancer Incidence in Five Continents, Vol. XI. International Agency for Re-search on Cancer. (Disponible en http://ci5.iarc.fr/CI5I-X/old/vol10/CI5vol10.pdf). [acceso: 01/06/2018].
21. Martínez-García MA, Campos-Rodriguez F, Durán-Cantolla J, de la Peña M, et al. Obstructive sleep apnea is associated with cancer mortality in younger patients. Sleep Medicine. 2014; 15 (7): 742-748.
22. Nathaniel S, Marshall PhD, Keith KH, Wong MB, et al. Sleep Apnea and 20-Year Follow-Up for All-Cause Mortality, Stroke, and Cancer Incidence and Mortality in the Busselton.Health Study Cohort. Journal of Clinical Sleep Medicine. 2014; 10 (4). (http://dx.doi.org/10.5664/jcsm.3600). [acceso: 10/07/2018].
23. Shantha GPS, Kumar AA, Cheskin LJ, Pancholy SB. Association between sleep-disordered breathing, obstructive sleep apnea, and cancer incidence: a systematic review and metaanalysis. Sleep Med. 2015; 16(10):1289–1294.
24. Christensen AS, Clark A, Salo P, Nymann P, et al. Symptoms of sleep disordered breathing and risk of cancer: A prospective cohort study. Sleep. 2013; 36:1429-35.
25. Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep 2016; 39(8):1493–1500.
26. Chang WP, Liu ME, Chang WC, Yang AC, et al. Sleep apnea and the subsequent risk of breast cancer in women: A nation-wide population-based cohort study. Sleep Med. 2014;15:1016–20.
27. Martinez-Garcia MA, Martorell A, Nagore E, Valero I, et al. Association between sleep disordered breathing and aggressive-ness markers of malignant cutaneous melanoma. Eur Respir J. 2014; 43:1661–8.
28. Martinez-Garcia M, Campos-Rodriguez F, Nagore E, Martorell A, et al. Sleep-disordered breathing is independently associated with increased aggressiveness of cutaneous melanoma. A multicenter observational study in 443 patients. Chest. 2018; 154. (Disponible doi 10.1016/j.chest.2018.07.015). [acceso: 01/05/2018].
29. Li M, Wang YX, Luo Y, Zhao J, et al. Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells. Oncology reports 2016;36:521-527.
30. Chung SD, Hung SH, Lin HC, Tsai MC, Kao LT. Obstructive sleep apnea and urological comorbidities in males: a population-based study. Sleep breath 2016; (Disponible doi 10.1007/s11325-016-1336-x.). [acceso: 10/05/2018].
31. Chen J-C, Hwang J-H. Sleep apnea increased incidence of primary central nervous system cancers: A nationwide cohort study. Sleep Med. 2014;15: 749–54
32. Sociedad Española de Oncología Médica (SEOM). Las cifras del cáncer en España 2018.(Disponible https://seom.org/seomcms/images/stories/recursos/Las_Cifras_del_cancer_en_Espana2018.pdf). [acceso: 15/05/2018].
33. Galceran J, Ameijide A, Carulla M, Mateos A, et al. REDECAN Working Group. Cancer incidence in Spain, 2015. Clin Transl Oncol. 2017 Jul;19(7):799-825.

Novedades
Estadísticas
Cómo citar
1.
Castilla Perera, Diana E; Burgos Díez, Paloma; del Campo Matías, Félix; Ruíz Albi, Tomás. Estudio comparativo de la tasa de incidencia de cáncer entre pacientes con Síndrome de Apneas-Hipoapneas durante el Sueño y la población general. Evidentia. 2019; 16. Disponible en: http://ciberindex.com/c/ev/e12258 [acceso: 15/12/2019]
Sección
Originales
Comentarios

DEJA TU COMENTARIO     VER 0 COMENTARIOS

Normas y uso de comentarios


Hay un total de 0 comentarios


INTRODUCIR NUEVO COMENTARIO

Para enviar un comentario, rellene los campos situados debajo. Recuerde que es obligatorio indicar un nombre y un email para enviar su comentario (el email no sera visible en el comentario).

Nombre:
e-mail:
Comentario: